Diageo, the world's largest spirits maker, is set to update investors on November 5th, and UBS analysts are betting the company will return to organic sales growth in its fiscal first quarter. The investment bank forecasts organic sales will rise 0.7%, a sharp contrast to the consensus estimate of a 0.8% decline, according to Visible Alpha data.
UBS said it sees "slight" improvement over the quarter, with the gap versus consensus largely driven by North America. There, the bank expects shipments to run ahead of "depletions" — the pace at which retailers actually sell through inventory. That can flatter near-term sales figures, but often reverses when inventories are reset at half-year and full-year checkpoints.
US competitive picture remains the key question
Beyond the headline sales number, the bigger issue for Diageo is its competitive position in the United States, its most profitable market. After the company's recent investor day, UBS said there is still no clear evidence that Diageo is winning volume share — meaning it is selling more bottles than rivals. Even with some targeted price changes, the bank believes the company has yet to show it can consistently gain ground against competitors like Pernod Ricard, which recently reported sales declines that were less severe than feared, helped by strength in India.
Diageo has been grappling with a slowdown in US spirits demand, particularly in the brown spirits category, as consumers trade down or switch to other beverages. The company has responded with price adjustments and marketing pushes, but UBS suggests these efforts have not yet translated into measurable market share gains.
Currency headwinds and profit forecast cuts
While the near-term sales outlook has improved, UBS trimmed its fiscal 2027 adjusted earnings per share forecast by 1%, citing a stronger US dollar. A firmer dollar reduces the value of overseas profits when converted back to pounds, a familiar challenge for multinational companies. The bank also lowered its earnings and operating-profit forecasts for fiscal 2028 and 2029.
Despite the cuts, UBS kept a neutral rating and an 18.50-pound price target on the London-listed stock. That combination — lower profit forecasts but an unchanged price target — implies the stock's value now rests more on investors being willing to pay a higher multiple for each pound of earnings, a concept known as a "re-rating."
This shift is significant. A re-rating is harder to achieve than a one-quarter sales beat, because it depends on sustained confidence in the company's long-term growth prospects, not just a temporary uptick in shipments.
What it means for investors
For everyday investors, the November 5th update will be less about whether organic sales come in a little better than expected, and more about whether Diageo can demonstrate progress in the US that would justify a higher valuation multiple. If the company shows it is winning back volume share, the stock could see a meaningful re-rating. If not, even a modest sales beat may not be enough to move the needle.
Diageo's performance also matters for the broader UK market. The company is a heavyweight in the FTSE 100, which recently hit a fresh high as banks rallied on fiscal discipline talk. A strong update from Diageo could support the index, while a disappointment could weigh on sentiment.
Investors should also keep an eye on currency movements. The stronger dollar is a headwind for Diageo's reported profits, and any further appreciation could lead to more forecast cuts. Conversely, a weaker dollar would provide a tailwind.
UBS's neutral stance reflects the uncertainty. The bank sees value in the stock at current levels, but it is not convinced that Diageo has turned the corner in its most important market. The November update will be a key test.
For those holding Diageo shares, the takeaway is to focus on the US volume share trends and any commentary on inventory levels. A clear improvement in depletions would be a positive signal, while continued weakness could mean the stock remains range-bound.
As always, past performance is not a guide to future returns, and individual circumstances vary. But understanding the key drivers — US market share, currency moves, and inventory dynamics — can help investors make more informed decisions.
